Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele d'Angelo

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Journal of Cellular Physiology|October 14, 2016
PPARα Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary CellsElisabetta Benedetti, Michele d'Angelo, Alessandra Ammazzalorso, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 11, 2023
Ketoprofen, lysine and gabapentin co-crystal magnifies synergistic efficacy and tolerability of the constituent drugs: Pre-clinical evidences towards an innovative therapeutic approach for neuroinflammatory painAndrea Aramini, Gianluca Bianchini, Samuele Lillini, et al.
Journal of Cellular Physiology|September 24, 2017
Targeted therapy of human glioblastoma via delivery of a toxin through a peptide directed to cell surface nucleolinAnne-Chloé Dhez, Elisabetta Benedetti, Andrea Antonosante, et al.
Cell Death & Disease|May 25, 2022
Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactionsLaura Brandolini, Michele d'Angelo, Rubina Novelli, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Journal of Cellular Physiology|October 14, 2016
PPARα Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary CellsElisabetta Benedetti, Michele d'Angelo, Alessandra Ammazzalorso, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 11, 2023
Ketoprofen, lysine and gabapentin co-crystal magnifies synergistic efficacy and tolerability of the constituent drugs: Pre-clinical evidences towards an innovative therapeutic approach for neuroinflammatory painAndrea Aramini, Gianluca Bianchini, Samuele Lillini, et al.
Journal of Cellular Physiology|September 24, 2017
Targeted therapy of human glioblastoma via delivery of a toxin through a peptide directed to cell surface nucleolinAnne-Chloé Dhez, Elisabetta Benedetti, Andrea Antonosante, et al.
Cell Death & Disease|May 25, 2022
Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactionsLaura Brandolini, Michele d'Angelo, Rubina Novelli, et al.
Pageof 9